Healthcare provider profile · identity verified

Richard M Oley, D.O.

Family Practice · DALLAS, PA · NPI 1891754719

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	763	188
Rosuvastatin Calcium	Rosuvastatin Calcium	506	125
Lisinopril	Lisinopril	479	140
Amlodipine Besylate	Amlodipine Besylate	433	105
Metoprolol Succinate	Metoprolol Succinate	335	82
Levothyroxine Sodium	Levothyroxine Sodium	312	76
Metformin Hcl	Metformin Hcl	307	77
Losartan Potassium	Losartan Potassium	275	78
Omeprazole	Omeprazole	273	69
Tamsulosin Hcl	Tamsulosin Hcl	271	65
Pantoprazole Sodium	Pantoprazole Sodium	242	56
Furosemide	Furosemide	232	48
Alprazolam	Alprazolam	230	45
Jardiance	Empagliflozin	207	40
Sertraline Hcl	Sertraline Hcl	199	44
Gabapentin	Gabapentin	184	44
Allopurinol	Allopurinol	180	37
Clopidogrel	Clopidogrel Bisulfate	177	44
Carvedilol	Carvedilol	159	31
Ozempic	Semaglutide	155	25
Eliquis	Apixaban	153	28
Hydrochlorothiazide	Hydrochlorothiazide	153	44
Metoprolol Tartrate	Metoprolol Tartrate	153	39
Famotidine	Famotidine	127	39
Atenolol	Atenolol	117	30
Fluticasone Propionate	Fluticasone Propionate	115	42
Potassium Chloride	Potassium Chloride	112	23
Albuterol Sulfate Hfa	Albuterol Sulfate	109	44
Simvastatin	Simvastatin	106	29
Glimepiride	Glimepiride	102	21
Metformin Hcl Er	Metformin Hcl	101	27
Ezetimibe	Ezetimibe	97	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	suppressed
Tramadol Hcl	Tramadol Hcl	91	21
Ibandronate Sodium	Ibandronate Sodium	89	13
Pravastatin Sodium	Pravastatin Sodium	89	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	19
Warfarin Sodium	Warfarin Sodium	87	21
Citalopram Hbr	Citalopram Hydrobromide	85	20
Pioglitazone Hcl	Pioglitazone Hcl	83	21
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	64	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	62	14
Trazodone Hcl	Trazodone Hcl	61	16
Benazepril Hcl	Benazepril Hcl	57	suppressed
Montelukast Sodium	Montelukast Sodium	55	15
Tradjenta	Linagliptin	53	suppressed
Lorazepam	Lorazepam	51	suppressed
Finasteride	Finasteride	50	14
Synthroid	Levothyroxine Sodium	50	11
Xarelto	Rivaroxaban	50	suppressed
Prednisone	Prednisone	47	36
Diazepam	Diazepam	44	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	43	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	12
Memantine Hcl	Memantine Hcl	43	suppressed
Azithromycin	Azithromycin	42	29
Rybelsus	Semaglutide	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	15
Spironolactone	Spironolactone	35	suppressed
Celecoxib	Celecoxib	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Chlorthalidone	Chlorthalidone	33	11
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Risedronate Sodium	Risedronate Sodium	32	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Spiriva Respimat	Tiotropium Bromide	31	suppressed
Torsemide	Torsemide	31	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Clonazepam	Clonazepam	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Valsartan	Valsartan	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	23
Pregabalin	Pregabalin	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	21
Tresiba Flextouch U-100	Insulin Degludec	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Glipizide	Glipizide	26	suppressed
Mometasone Furoate	Mometasone Furoate	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Ramipril	Ramipril	26	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	18
Baclofen	Baclofen	24	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Cilostazol	Cilostazol	23	suppressed
Lactulose	Lactulose	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Januvia	Sitagliptin Phosphate	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Cholestyramine	Cholestyramine (With Sugar)	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Nadolol	Nadolol	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Colchicine	Colchicine	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	11
Verapamil Er	Verapamil Hcl	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Digoxin	Digoxin	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	12
Penicillin V Potassium	Penicillin V Potassium	13	suppressed
Cephalexin	Cephalexin	12	11
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Naproxen	Naproxen	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error